Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Quoin Pharmaceuticals Ltd. is a late-stage specialty pharmaceutical company focused on developing and commercializing treatments for rare and orphan diseases, primarily in dermatology. Its pipeline includes products like QRX003 for Netherton Syndrome, utilizing proprietary drug delivery technologies. The company targets global markets through partnerships, aiming to address unmet medical needs with innovative, regulatory-approved therapies for small patient populations.
This description was generated via AI from an annual report. Updated about 1 year ago.